KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Divestments (2020 - 2025)

Historic Divestments for Pfizer (PFE) over the last 6 years, with Q1 2025 value amounting to $6.3 billion.

  • Pfizer's Divestments rose 8077.91% to $6.3 billion in Q1 2025 from the same period last year, while for Sep 2025 it was $9.8 billion, marking a year-over-year increase of 4038.96%. This contributed to the annual value of $7.0 billion for FY2024, which is N/A changed from last year.
  • Latest data reveals that Pfizer reported Divestments of $6.3 billion as of Q1 2025, which was up 8077.91% from $3.5 billion recorded in Q3 2024.
  • In the past 5 years, Pfizer's Divestments ranged from a high of $6.3 billion in Q1 2025 and a low of -$8.0 million during Q4 2021
  • Moreover, its 4-year median value for Divestments was $3.5 billion (2024), whereas its average is $2.9 billion.
  • In the last 5 years, Pfizer's Divestments surged by 4960000.0% in 2022 and then soared by 8077.91% in 2025.
  • Pfizer's Divestments (Quarter) stood at -$8.0 million in 2021, then surged by 49600.0% to $4.0 billion in 2022, then fell by 11.84% to $3.5 billion in 2024, then skyrocketed by 80.78% to $6.3 billion in 2025.
  • Its last three reported values are $6.3 billion in Q1 2025, $3.5 billion for Q3 2024, and $3.5 billion during Q1 2024.